Loading data for FTH — first visit, this takes a few seconds.

Faeth Therapeutics Inc.

NasdaqCM: FTH · 실시간 가격 · USD
33.00
+0.23 (0.70%)
종가 기준: Aug 18, 2026, 8:00 PM
34.00
+3.03%
프리마켓: 7:52 AM

Faeth Therapeutics Inc. (FTH) Stock Price, Analysis & Data

0.70%

데이터 없음

매수호가34.01
시가총액852.73M
매출 (ttm)n/a
순이익 (ttm)-195.53M
베타-0.31
EPS (ttm)-60.86
P/E (ttm)n/a
선행 P/E-6.65
P/B (ttm)4.93
P/S (ttm)n/a
Earnings DateNov 3, 2026
매도호가35
거래량334,323
평균 거래량 (20일)191,353
시가32.50
전일 종가32.77
일중 범위32.39 - 35.25
52주 범위7.21 - 37.90
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

FTH 소개

Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The...

섹터 Healthcare
IPO 일자 Feb 4, 2021
직원 수 29
상장 거래소 NasdaqCM
티커 FTH
전체 기업 정보

재무 실적

2025년 Faeth Therapeutics의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -21.09M로, -30.08% 감소했습니다.

재무제표